Market overview
The global medical cannula market is worth USD 2.3 bn in 2026 and is forecast to reach USD 3.9 bn by 2036, growing at a 5.3% CAGR. United States is the largest country market and IV cannulae is the largest by type segment.
| Scope | Hollow tubes inserted into veins, arteries and body cavities for infusion, sampling and drainage: IV cannulae, arterial and nasal cannulae and surgical cannulae. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 2.2 bn |
| Value 2026 | USD 2.3 bn |
| Value 2036 | USD 3.9 bn |
| CAGR 2026-2036 | 5.3% |
| Volume 2026 | 3,989 million units |
| Volume 2036 | 6,361 million units |
| Average price 2026 | USD 0.58 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Medical Cannula market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 2.3 bn |
| 2027 | USD 2.4 bn |
| 2028 | USD 2.6 bn |
| 2029 | USD 2.7 bn |
| 2030 | USD 2.9 bn |
| 2031 | USD 3.0 bn |
| 2032 | USD 3.2 bn |
| 2033 | USD 3.3 bn |
| 2034 | USD 3.5 bn |
| 2035 | USD 3.7 bn |
| 2036 | USD 3.9 bn |
Medical Cannula market segmentation
By type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| IV cannulae | 64.0% | 62.0% | USD 1.5 bn | 5.0% |
| Nasal oxygen cannulae | 16.0% | 16.2% | USD 371 mn | 5.5% |
| Arterial and central cannulae | 10.0% | 10.6% | USD 232 mn | 6.0% |
| Surgical and other cannulae | 10.0% | 11.2% | USD 232 mn | 6.5% |
By end use
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 76.0% | 73.7% | USD 1.8 bn | 5.0% |
| Ambulatory and day care | 14.0% | 15.3% | USD 325 mn | 6.3% |
| Home care | 10.0% | 11.0% | USD 232 mn | 6.3% |
By material
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Polymer and plastic | 56.0% | 55.0% | USD 1.3 bn | 5.1% |
| Stainless steel | 16.0% | 14.0% | USD 371 mn | 3.9% |
| Silicone | 14.0% | 15.0% | USD 325 mn | 6.0% |
| Others combined | 14.0% | 16.0% | USD 325 mn | 6.7% |
By application
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Intravenous access | 44.0% | 42.0% | USD 1.0 bn | 4.8% |
| Arterial and cardiac | 16.0% | 17.0% | USD 371 mn | 5.9% |
| Nasal and respiratory | 14.0% | 14.0% | USD 325 mn | 5.3% |
| Surgical drainage and suction | 14.0% | 14.0% | USD 325 mn | 5.3% |
| Dialysis and apheresis | 12.0% | 13.0% | USD 279 mn | 6.2% |
By gauge size
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Small (above 20 G) | 28.0% | 27.0% | USD 650 mn | 4.9% |
| Medium (14 to 20 G) | 46.0% | 46.0% | USD 1.1 bn | 5.3% |
| Large (below 14 G) | 26.0% | 27.0% | USD 603 mn | 5.7% |
Top 25 countries for medical cannula by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 75.5% of 2026 revenue and the 25 countries below together hold 93.1%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 557 mn | 24.0% | USD 848 mn | 4.3% |
| 2 | China | USD 395 mn | 17.0% | USD 727 mn | 6.3% |
| 3 | India | USD 186 mn | 8.0% | USD 412 mn | 8.3% |
| 4 | Germany | USD 139 mn | 6.0% | USD 214 mn | 4.4% |
| 5 | Japan | USD 116 mn | 5.0% | USD 167 mn | 3.7% |
| 6 | Brazil | USD 81 mn | 3.5% | USD 136 mn | 5.3% |
| 7 | France | USD 81 mn | 3.5% | USD 124 mn | 4.4% |
| 8 | United Kingdom | USD 70 mn | 3.0% | USD 105 mn | 4.2% |
| 9 | Italy | USD 70 mn | 3.0% | USD 105 mn | 4.2% |
| 10 | Indonesia | USD 58 mn | 2.5% | USD 117 mn | 7.2% |
| 11 | South Korea | USD 56 mn | 2.4% | USD 127 mn | 8.5% |
| 12 | Mexico | USD 56 mn | 2.4% | USD 118 mn | 7.7% |
| 13 | Turkey | USD 56 mn | 2.4% | USD 95 mn | 5.3% |
| 14 | Russia | USD 55 mn | 2.4% | USD 75 mn | 3.3% |
| 15 | Australia | USD 41 mn | 1.8% | USD 56 mn | 3.3% |
| 16 | Canada | USD 31 mn | 1.4% | USD 43 mn | 3.3% |
| 17 | Netherlands | USD 25 mn | 1.1% | USD 35 mn | 3.3% |
| 18 | Poland | USD 20 mn | 0.9% | USD 28 mn | 3.3% |
| 19 | Thailand | USD 17 mn | 0.8% | USD 24 mn | 3.1% |
| 20 | Malaysia | USD 13 mn | 0.6% | USD 18 mn | 3.3% |
| 21 | Pakistan | USD 11 mn | 0.5% | USD 15 mn | 3.1% |
| 22 | Saudi Arabia | USD 9.3 mn | 0.4% | USD 13 mn | 3.3% |
| 23 | Egypt | USD 7.2 mn | 0.3% | USD 9.7 mn | 3.1% |
| 24 | Vietnam | USD 5.8 mn | 0.2% | USD 8.2 mn | 3.5% |
| 25 | Sweden | USD 4.6 mn | 0.2% | USD 6.6 mn | 3.6% |
| Rest of world | USD 160 mn | 6.9% | USD 262 mn | 5.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- BD
- B. Braun
- Terumo
- Smiths Medical
- ICU Medical
- Fresenius Kabi
Group 2: Regional and specialist players
- Medline
- Teleflex
- Nipro
- Poly Medicure
- Hindustan Syringes and Medical Devices
- Shandong Weigao
- Fisher and Paykel Healthcare
- Intersurgical
Group 3: Emerging and niche players
- Vygon
- Romsons
- Salter Labs
- Westmed
- SOL-Millennium
- Retractable Technologies
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the medical cannula market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.3% is calculated from the resulting values.
The market is divided by type, by end use, by material, by application, by gauge size. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the medical cannula market?
The global medical cannula market is estimated at USD 2.2 bn in 2025 and USD 2.3 bn in 2026.
How fast will the medical cannula market grow?
It is forecast to reach USD 3.9 bn by 2036, a compound annual growth rate of 5.3% from 2026, an increase of USD 1.6 bn.
Which country is the largest market for medical cannula?
United States is the largest market by revenue at USD 557 mn in 2026, 24.0% of the global total. The three largest countries together hold 49.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 8.3% a year from 2026 to 2036.
Which medical cannula segment is largest?
In the by type split, IV cannulae is the largest segment with 64.0% of 2026 revenue.
Who are the leading medical cannula companies?
Global leaders include BD, B. Braun, Terumo, Smiths Medical.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Point-of-Care Respiratory Diagnostic PanelsUSD 2.2 bn · 6.5% CAGR
- Amniotic MembraneUSD 2.2 bn · 8.5% CAGR
- New Approach Methodologies Nonclinical TestingUSD 2.2 bn · 13.0% CAGR
- Tangential Flow FiltrationUSD 2.5 bn · 9.0% CAGR
- Cardiovascular Drug DiscoveryUSD 2.6 bn · 7.5% CAGR
- Chromatography ResinUSD 2.6 bn · 9.8% CAGR
- Dental SterilizationUSD 2.0 bn · 6.0% CAGR
- 3D Cell CultureUSD 2.7 bn · 12.0% CAGR
← Medical Billing Medical Device Cyber Risk Quantification →